Press Release Contact

Press release:
Mandara Biopharma Launches Their Phase 2/3 Clinical Trial for Alzheimer’s Agitation
August 17, 2026, 12:00 GMT

For questions about this press release, please contact the person or organization listed below.

David Hurley
Mandara Biopharma Inc.
+1 808-497-7771
Visit us on social media:
LinkedIn
Instagram